 | • レポートコード：MRC2Q12-17015 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、生体耐久性眼球インプラントのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 生体耐久性眼球インプラントのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生体耐久性眼球インプラントの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生体耐久性眼球インプラントのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの生体耐久性眼球インプラントの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の生体耐久性眼球インプラントの売上および2028年までの予測に焦点を当てています。 生体耐久性眼球インプラントのグローバル主要企業には、Glaukos Corp、Ocular Therapeutix、Santen Pharmaceutical、pSivida、Clearside Biomedical、Bausch Health、AptarGroup、Boehringer Ingelheim、Allergan、Re-Vana Therapeutics、PolyActiva、Genentechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 生体耐久性眼球インプラント市場は、タイプとアプリケーションによって区分されます。世界の生体耐久性眼球インプラント市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 前方薬物送達法、後方薬物送達法 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 生体耐久性眼球インプラント製品概要 - タイプ別市場（前方薬物送達法、後方薬物送達法） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の生体耐久性眼球インプラント販売量予測2017-2028 - 世界の生体耐久性眼球インプラント売上予測2017-2028 - 生体耐久性眼球インプラントの地域別販売量 - 生体耐久性眼球インプラントの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別生体耐久性眼球インプラント販売量 - 主要メーカー別生体耐久性眼球インプラント売上 - 主要メーカー別生体耐久性眼球インプラント価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（前方薬物送達法、後方薬物送達法） - 生体耐久性眼球インプラントのタイプ別販売量 - 生体耐久性眼球インプラントのタイプ別売上 - 生体耐久性眼球インプラントのタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 生体耐久性眼球インプラントのアプリケーション別販売量 - 生体耐久性眼球インプラントのアプリケーション別売上 - 生体耐久性眼球インプラントのアプリケーション別価格 ・北米市場 - 北米の生体耐久性眼球インプラント市場規模（タイプ別、アプリケーション別） - 主要国別の生体耐久性眼球インプラント市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの生体耐久性眼球インプラント市場規模（タイプ別、アプリケーション別） - 主要国別の生体耐久性眼球インプラント市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の生体耐久性眼球インプラント市場規模（タイプ別、アプリケーション別） - 主要国別の生体耐久性眼球インプラント市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の生体耐久性眼球インプラント市場規模（タイプ別、アプリケーション別） - 主要国別の生体耐久性眼球インプラント市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの生体耐久性眼球インプラント市場規模（タイプ別、アプリケーション別） - 主要国別の生体耐久性眼球インプラント市場規模（トルコ、サウジアラビア） ・企業情報 Glaukos Corp、Ocular Therapeutix、Santen Pharmaceutical、pSivida、Clearside Biomedical、Bausch Health、AptarGroup、Boehringer Ingelheim、Allergan、Re-Vana Therapeutics、PolyActiva、Genentech ・産業チェーン及び販売チャネル分析 - 生体耐久性眼球インプラントの産業チェーン分析 - 生体耐久性眼球インプラントの原材料 - 生体耐久性眼球インプラントの生産プロセス - 生体耐久性眼球インプラントの販売及びマーケティング - 生体耐久性眼球インプラントの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 生体耐久性眼球インプラントの産業動向 - 生体耐久性眼球インプラントのマーケットドライバー - 生体耐久性眼球インプラントの課題 - 生体耐久性眼球インプラントの阻害要因 ・主な調査結果 |
Biodurable implants do not break down over time and may be removed or refilled once the treatment is complete.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Biodurable Ocular Implant is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Biodurable Ocular Implant is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Biodurable Ocular Implant is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Biodurable Ocular Implant include Glaukos Corp, Ocular Therapeutix, Santen Pharmaceutical, pSivida, Clearside Biomedical, Bausch Health, AptarGroup, Boehringer Ingelheim and Allergan, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biodurable Ocular Implant manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Biodurable Ocular Implant market. Further, it explains the major drivers and regional dynamics of the global Biodurable Ocular Implant market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Glaukos Corp
Ocular Therapeutix
Santen Pharmaceutical
pSivida
Clearside Biomedical
Bausch Health
AptarGroup
Boehringer Ingelheim
Allergan
Re-Vana Therapeutics
PolyActiva
Genentech
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Biodurable Ocular Implant Segment by Type
Anterior Drug Delivery Methods
Posterior Drug Delivery Methods
Biodurable Ocular Implant Segment by Application
Hospitals
Clinics
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biodurable Ocular Implant market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Biodurable Ocular Implant, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Biodurable Ocular Implant, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Biodurable Ocular Implant, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biodurable Ocular Implant sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Biodurable Ocular Implant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Biodurable Ocular Implant sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Glaukos Corp, Ocular Therapeutix, Santen Pharmaceutical, pSivida, Clearside Biomedical, Bausch Health, AptarGroup, Boehringer Ingelheim and Allergan, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Biodurable Ocular Implant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Biodurable Ocular Implant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biodurable Ocular Implant sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Biodurable Ocular Implant Product Introduction
1.2 Market by Type
1.2.1 Global Biodurable Ocular Implant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anterior Drug Delivery Methods
1.2.3 Posterior Drug Delivery Methods
1.3 Market by Application
1.3.1 Global Biodurable Ocular Implant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biodurable Ocular Implant Sales Estimates and Forecasts 2017-2028
2.2 Global Biodurable Ocular Implant Revenue Estimates and Forecasts 2017-2028
2.3 Global Biodurable Ocular Implant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biodurable Ocular Implant Sales by Region
2.4.1 Global Biodurable Ocular Implant Sales by Region (2017-2022)
2.4.2 Global Sales Biodurable Ocular Implant by Region (2023-2028)
2.5 Global Biodurable Ocular Implant Revenue by Region
2.5.1 Global Biodurable Ocular Implant Revenue by Region (2017-2022)
2.5.2 Global Biodurable Ocular Implant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biodurable Ocular Implant Sales by Manufacturers
3.1.1 Global Top Biodurable Ocular Implant Manufacturers by Sales (2017-2022)
3.1.2 Global Biodurable Ocular Implant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biodurable Ocular Implant in 2021
3.2 Global Biodurable Ocular Implant Revenue by Manufacturers
3.2.1 Global Biodurable Ocular Implant Revenue by Manufacturers (2017-2022)
3.2.2 Global Biodurable Ocular Implant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biodurable Ocular Implant Revenue in 2021
3.3 Global Biodurable Ocular Implant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biodurable Ocular Implant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biodurable Ocular Implant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biodurable Ocular Implant Sales by Type
4.1.1 Global Biodurable Ocular Implant Historical Sales by Type (2017-2022)
4.1.2 Global Biodurable Ocular Implant Forecasted Sales by Type (2023-2028)
4.1.3 Global Biodurable Ocular Implant Sales Market Share by Type (2017-2028)
4.2 Global Biodurable Ocular Implant Revenue by Type
4.2.1 Global Biodurable Ocular Implant Historical Revenue by Type (2017-2022)
4.2.2 Global Biodurable Ocular Implant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biodurable Ocular Implant Revenue Market Share by Type (2017-2028)
4.3 Global Biodurable Ocular Implant Price by Type
4.3.1 Global Biodurable Ocular Implant Price by Type (2017-2022)
4.3.2 Global Biodurable Ocular Implant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biodurable Ocular Implant Sales by Application
5.1.1 Global Biodurable Ocular Implant Historical Sales by Application (2017-2022)
5.1.2 Global Biodurable Ocular Implant Forecasted Sales by Application (2023-2028)
5.1.3 Global Biodurable Ocular Implant Sales Market Share by Application (2017-2028)
5.2 Global Biodurable Ocular Implant Revenue by Application
5.2.1 Global Biodurable Ocular Implant Historical Revenue by Application (2017-2022)
5.2.2 Global Biodurable Ocular Implant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biodurable Ocular Implant Revenue Market Share by Application (2017-2028)
5.3 Global Biodurable Ocular Implant Price by Application
5.3.1 Global Biodurable Ocular Implant Price by Application (2017-2022)
5.3.2 Global Biodurable Ocular Implant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biodurable Ocular Implant Market Size by Type
6.1.1 North America Biodurable Ocular Implant Sales by Type (2017-2028)
6.1.2 North America Biodurable Ocular Implant Revenue by Type (2017-2028)
6.2 North America Biodurable Ocular Implant Market Size by Application
6.2.1 North America Biodurable Ocular Implant Sales by Application (2017-2028)
6.2.2 North America Biodurable Ocular Implant Revenue by Application (2017-2028)
6.3 North America Biodurable Ocular Implant Market Size by Country
6.3.1 North America Biodurable Ocular Implant Sales by Country (2017-2028)
6.3.2 North America Biodurable Ocular Implant Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Biodurable Ocular Implant Market Size by Type
7.1.1 Europe Biodurable Ocular Implant Sales by Type (2017-2028)
7.1.2 Europe Biodurable Ocular Implant Revenue by Type (2017-2028)
7.2 Europe Biodurable Ocular Implant Market Size by Application
7.2.1 Europe Biodurable Ocular Implant Sales by Application (2017-2028)
7.2.2 Europe Biodurable Ocular Implant Revenue by Application (2017-2028)
7.3 Europe Biodurable Ocular Implant Market Size by Country
7.3.1 Europe Biodurable Ocular Implant Sales by Country (2017-2028)
7.3.2 Europe Biodurable Ocular Implant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biodurable Ocular Implant Market Size by Type
8.1.1 Asia Pacific Biodurable Ocular Implant Sales by Type (2017-2028)
8.1.2 Asia Pacific Biodurable Ocular Implant Revenue by Type (2017-2028)
8.2 Asia Pacific Biodurable Ocular Implant Market Size by Application
8.2.1 Asia Pacific Biodurable Ocular Implant Sales by Application (2017-2028)
8.2.2 Asia Pacific Biodurable Ocular Implant Revenue by Application (2017-2028)
8.3 Asia Pacific Biodurable Ocular Implant Market Size by Region
8.3.1 Asia Pacific Biodurable Ocular Implant Sales by Region (2017-2028)
8.3.2 Asia Pacific Biodurable Ocular Implant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biodurable Ocular Implant Market Size by Type
9.1.1 Latin America Biodurable Ocular Implant Sales by Type (2017-2028)
9.1.2 Latin America Biodurable Ocular Implant Revenue by Type (2017-2028)
9.2 Latin America Biodurable Ocular Implant Market Size by Application
9.2.1 Latin America Biodurable Ocular Implant Sales by Application (2017-2028)
9.2.2 Latin America Biodurable Ocular Implant Revenue by Application (2017-2028)
9.3 Latin America Biodurable Ocular Implant Market Size by Country
9.3.1 Latin America Biodurable Ocular Implant Sales by Country (2017-2028)
9.3.2 Latin America Biodurable Ocular Implant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Biodurable Ocular Implant Market Size by Type
10.1.1 Middle East and Africa Biodurable Ocular Implant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biodurable Ocular Implant Revenue by Type (2017-2028)
10.2 Middle East and Africa Biodurable Ocular Implant Market Size by Application
10.2.1 Middle East and Africa Biodurable Ocular Implant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biodurable Ocular Implant Revenue by Application (2017-2028)
10.3 Middle East and Africa Biodurable Ocular Implant Market Size by Country
10.3.1 Middle East and Africa Biodurable Ocular Implant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biodurable Ocular Implant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Glaukos Corp
11.1.1 Glaukos Corp Corporation Information
11.1.2 Glaukos Corp Overview
11.1.3 Glaukos Corp Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Glaukos Corp Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Glaukos Corp Recent Developments
11.2 Ocular Therapeutix
11.2.1 Ocular Therapeutix Corporation Information
11.2.2 Ocular Therapeutix Overview
11.2.3 Ocular Therapeutix Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ocular Therapeutix Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ocular Therapeutix Recent Developments
11.3 Santen Pharmaceutical
11.3.1 Santen Pharmaceutical Corporation Information
11.3.2 Santen Pharmaceutical Overview
11.3.3 Santen Pharmaceutical Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Santen Pharmaceutical Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Santen Pharmaceutical Recent Developments
11.4 pSivida
11.4.1 pSivida Corporation Information
11.4.2 pSivida Overview
11.4.3 pSivida Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 pSivida Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 pSivida Recent Developments
11.5 Clearside Biomedical
11.5.1 Clearside Biomedical Corporation Information
11.5.2 Clearside Biomedical Overview
11.5.3 Clearside Biomedical Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Clearside Biomedical Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Clearside Biomedical Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Corporation Information
11.6.2 Bausch Health Overview
11.6.3 Bausch Health Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bausch Health Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bausch Health Recent Developments
11.7 AptarGroup
11.7.1 AptarGroup Corporation Information
11.7.2 AptarGroup Overview
11.7.3 AptarGroup Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AptarGroup Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AptarGroup Recent Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Corporation Information
11.8.2 Boehringer Ingelheim Overview
11.8.3 Boehringer Ingelheim Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Boehringer Ingelheim Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boehringer Ingelheim Recent Developments
11.9 Allergan
11.9.1 Allergan Corporation Information
11.9.2 Allergan Overview
11.9.3 Allergan Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Allergan Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Allergan Recent Developments
11.10 Re-Vana Therapeutics
11.10.1 Re-Vana Therapeutics Corporation Information
11.10.2 Re-Vana Therapeutics Overview
11.10.3 Re-Vana Therapeutics Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Re-Vana Therapeutics Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Re-Vana Therapeutics Recent Developments
11.11 PolyActiva
11.11.1 PolyActiva Corporation Information
11.11.2 PolyActiva Overview
11.11.3 PolyActiva Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 PolyActiva Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 PolyActiva Recent Developments
11.12 Genentech
11.12.1 Genentech Corporation Information
11.12.2 Genentech Overview
11.12.3 Genentech Biodurable Ocular Implant Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Genentech Biodurable Ocular Implant Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Genentech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biodurable Ocular Implant Industry Chain Analysis
12.2 Biodurable Ocular Implant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biodurable Ocular Implant Production Mode & Process
12.4 Biodurable Ocular Implant Sales and Marketing
12.4.1 Biodurable Ocular Implant Sales Channels
12.4.2 Biodurable Ocular Implant Distributors
12.5 Biodurable Ocular Implant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biodurable Ocular Implant Industry Trends
13.2 Biodurable Ocular Implant Market Drivers
13.3 Biodurable Ocular Implant Market Challenges
13.4 Biodurable Ocular Implant Market Restraints
14 Key Findings in The Global Biodurable Ocular Implant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer